Parallax Volatility Advisers
MRNA icon

Parallax Volatility Advisers’s Moderna MRNA Stock Holding History

Parallax Volatility Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,900
Closed -$587K – 1720
2025
Q4 		$587K Sell
19,900
-124,900
-86% -$3.39M ﹤0.01% 1202
2025
Q3 		$3.74M Buy
144,800
+34,900
+32% +$974K 0.01% 753
2025
Q2 		$3.03M Sell
109,900
-70,000
-39% -$1.84M 0.01% 760
2025
Q1 		$5.1M Sell
179,900
-118,800
-40% -$4.22M 0.01% 612
2024
Q4 		$12.4M Buy
298,700
+73,100
+32% +$3.49M 0.02% 497
2024
Q3 		$15.1M Buy
225,600
+167,300
+287% +$15.4M 0.03% 409
2024
Q2 		$6.92M Buy
58,300
+10,000
+21% +$1.27M 0.01% 604
2024
Q1 		$5.15M Sell
48,300
-800
-2% -$80.6K 0.01% 722
2023
Q4 		$4.88M Sell
49,100
-53,700
-52% -$4.52M 0.01% 846
2023
Q3 		$10.6M Sell
102,800
-124,400
-55% -$13.9M 0.02% 515
2023
Q2 		$27.6M Sell
227,200
-85,200
-27% -$11.4M 0.06% 268
2023
Q1 		$48M Sell
312,400
-577,600
-65% -$95.3M 0.1% 199
2022
Q4 		$160M Sell
890,000
-212,500
-19% -$34.7M 0.25% 61
2022
Q3 		$130M Buy
1,102,500
+322,900
+41% +$49M 0.2% 81
2022
Q2 		$111M Buy
779,600
+182,900
+31% +$26.1M 0.11% 134
2022
Q1 		$103M Sell
596,700
-747,400
-56% -$126M 0.05% 132
2021
Q4 		$341M Buy
1,344,100
+285,400
+27% +$83.4M 0.4% 27
2021
Q3 		$407M Buy
1,058,700
+679,900
+179% +$251M 0.39% 23
2021
Q2 		$89M Buy
+378,800
New +$67.7M 0.12% 117
2021
Q1 		– Sell
-73,000
Closed -$7.63M – 1938
2020
Q4 		$7.63M Sell
73,000
-2,900
-4% -$293K 0.01% 806
2020
Q3 		$5.37M Buy
+75,900
New +$5.29M ﹤0.01% 1280

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parallax Volatility Advisers's MRNA Position: Q1 2026 in Review

Parallax Volatility Advisers increased its Moderna (MRNA) stake by 59% in Q1 2026, buying an estimated $825K and bringing the position to 47,891 shares worth $2.6M. The position accounts for 0.01% of the portfolio, ranked #733.

Parallax Volatility Advisers first reported a position in MRNA in Q1 2020 and has held it in 21 quarters since. The position peaked at $27.4M in Q4 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Parallax Volatility Advisers held 47,891 shares of Moderna worth $2.6M as of Q1 2026.
  • Parallax Volatility Advisers bought 17,678 Moderna shares in Q1 2026, an estimated $825K.
  • Moderna made up 0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #733 holding.
  • Parallax Volatility Advisers first reported a position in Moderna in Q1 2020 and has held it in 21 quarters since.
  • Parallax Volatility Advisers's Moderna position peaked at $27.4M in Q4 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.